Condition: Unruptured Intracranial Aneurysm · Sponsor: Sim&Cure
In recent years, endovascular treatment of intracranial aneurysms has seen remarkable growth, now surpassing traditional surgical approaches in terms of frequency of use. However, this transition to endovascular methods is not without its challenges. This type of procedure requires careful selection of the device to be implanted, a decision that is still based on manual two-dimensional measurements. This method is questionable, as it does not always take into account the complexity and specificities of certain aneurysms, where three-dimensional geometry can play a crucial role. As a result, these procedures carry significant risks, such as the need for additional maneuvers to remove or reposition devices, or even deploy another support device, which potentially increases the risk of perioperative complications, the duration of surgery, and the amount of radiation required for imaging. Beyond the impact on the patient, these complications also result in additional costs for the healthcare system, expenses that could likely be avoided if more precise and appropriate tools were used from the outset of the procedure. In this context, optimizing the choice of endovascular devices could have both clinical and economic impacts. Innovative technology such as Sim\&Size, which supports healthcare professionals in their therapeutic decisions and choice of the appropriate endovascular device, should therefore improve the effectiveness and efficiency of endovascular treatments. Sim\&Size…
This description comes directly from the study's public registry record.
Amandine RENE · +33783477287 · a.rene@sim-and-cure.com
Always discuss trial participation with your own doctor first.
| CHU d'Angers | Angers, France | Recruiting |
| CHU de Bordeaux | Bordeaux, France | Recruiting |
| Hôpital Bicêtre AP-HP | Le Kremlin-Bicêtre, France | Recruiting |
| Hôpital de La Timone | Marseille, France | Not Yet Recruiting |
| Fondation Rothschild | Paris, France | Not Yet Recruiting |
| CHU de Reims | Reims, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07433075